<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>A417</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 6 4 5 2 3 4;}
@font-face
	{font-family:Albertus;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.PrefileFronterTitle, li.PrefileFronterTitle, div.PrefileFronterTitle
	{mso-style-name:PrefileFronterTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.StylePrefileFronterTitleLeft, li.StylePrefileFronterTitleLeft, div.StylePrefileFronterTitleLeft
	{mso-style-name:"Style PrefileFronterTitle + Left";
	margin-top:0in;
	margin-right:-.2in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times",serif;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.Superscript
	{mso-style-name:Superscript;
	font-family:"Albertus",sans-serif;
	font-weight:bold;
	vertical-align:super;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.amendfooter, li.amendfooter, div.amendfooter
	{mso-style-name:amendfooter;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.5in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.2in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>ASSEMBLY, No. 417 </p>

<p class=bpuWpGraphic></p>

<p class=bpuState>STATE OF NEW JERSEY</p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Assemblyman  ROBERT AUTH</p>

<p class=bpuSponsor>District 39 (Bergen and Passaic)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Pharmaceutical Representative Licensing Act. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     Introduced Pending Technical Review by Legislative
Counsel.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:10.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> concerning the licensure of pharmaceutical
representatives and supplementing chapter 9 of Title 45 of the Revised
Statutes.</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     1.    This act shall be known
and may be cited as the Pharmaceutical Representative Licensing Act.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     2.    As used in this act:</p>

<p class=MsoNormal style='line-height:150%'>     Board means the State Board
of Medical Examiners established pursuant to R.S.45:9-1.</p>

<p class=MsoNormal style='line-height:150%'>     Director means the Director
of Consumer Affairs in the Department of Law and Public Safety.</p>

<p class=MsoNormal style='line-height:150%'>     Pharmaceutical means a drug,
biological, or device that may legally be dispensed only with a valid
prescription from a practitioner.</p>

<p class=MsoNormal style='line-height:150%'>     Pharmaceutical
representative means an individual currently licensed by this State pursuant
to this act to engage in the marketing or promoting of pharmaceuticals to
practitioners.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3.    The board, in
consultation with the director, shall have the following powers and duties with
respect to the licensure of pharmaceutical representatives under this act:</p>

<p class=MsoNormal style='line-height:150%'>     a.     establish criteria and
standards for education and experience required for licensure;</p>

<p class=MsoNormal style='line-height:150%'>     b.    review the
qualifications of applicants for licensure;</p>

<p class=MsoNormal style='line-height:150%'>     c.     ensure proper conduct
and professional standards of practice;</p>

<p class=MsoNormal style='line-height:150%'>     d.    issue and renew
licenses;</p>

<p class=MsoNormal style='line-height:150%'>     e.     establish standards for
continuing education;</p>

<p class=MsoNormal style='line-height:150%'>     f.     maintain a record of
every pharmaceutical representative licensed in this State;</p>

<p class=MsoNormal style='line-height:150%'>     g.    establish fees for
licenses, including applications for licensure, renewals, and duplications of
lost licenses, and other services performed by the board;</p>

<p class=MsoNormal style='line-height:150%'>     h.    suspend, revoke, or
decline to renew the license of a pharmaceutical representative pursuant to the
provisions of this act and P.L.1978, c.73 (C.45:1-14 et seq.); and</p>

<p class=MsoNormal style='line-height:150%'>     i.     promulgate rules and
regulations to carry out matters concerning any provision of this act, in
conformance with the Administrative Procedure Act, P.L.1968, c.410
(C.52:14B-1 et seq.).</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     4.    It shall be unlawful for
any individual to engage in the practice of a pharmaceutical representative
unless currently licensed under the provisions of this act.<br clear=all
style='page-break-before:always'>
</p>

<p class=MsoNormal style='line-height:150%'>     5.    To obtain a license to
engage in the practice of a pharmaceutical representative, an applicant shall:</p>

<p class=MsoNormal style='line-height:150%'>     a.     submit an application
in the form prescribed by the board;</p>

<p class=MsoNormal style='line-height:150%'>     b.    have attained the age of
18 years;</p>

<p class=MsoNormal style='line-height:150%'>     c.     be of good moral character;</p>

<p class=MsoNormal style='line-height:150%'>     d.    complete a professional
education course as determined by the board and provide sufficient evidence
that the course was completed; </p>

<p class=MsoNormal style='line-height:150%'>     e.     provide any other
information that the board may deem necessary; and</p>

<p class=MsoNormal style='line-height:150%'>     f.     pay the fees prescribed
by the board.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     6.    a.   The board shall
require each pharmaceutical representative, as a condition for biennial license
renewal, to complete continuing education during each biennial period
immediately preceding the date of renewal and submit proof thereof to the board.</p>

<p class=MsoNormal style='line-height:150%'>     b.    The board shall require
each pharmaceutical representative to complete a minimum of six hours of
continuing education.  The continuing education shall include training in the
areas of ethics, pharmacology, laws and regulations applicable to pharmaceutical
marketing, prescription opioid drugs and alternatives to opioids for managing
and treating pain, and any other areas the board may determine.</p>

<p class=MsoNormal style='line-height:150%'>     c.     The board shall approve
continuing education courses, as well as providers and programs offering credit
towards pharmaceutical representative continuing education requirements, and
establish procedures for the issuance of credit upon satisfactory proof of the
completion of continuing education requirements.  In the case of continuing
education courses and programs, each hour of instruction shall be equivalent to
one credit.</p>

<p class=MsoNormal style='line-height:150%'>     d.    The board shall only
approve programs that are provided on a nondiscriminatory basis.  The board
shall prohibit employers of pharmaceutical representatives from providing
continuing education courses and programs.  In no event shall the board grant
continuing education credits for, or approve as, a component of a continuing
education course or program:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   participation in a
routine business portion of a meeting of a pharmaceutical representative
association or organization; or</p>

<p class=MsoNormal style='line-height:150%'>     (2)   any presentation that is
offered to sell a product or promote a business enterprise.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     7.    a.   Upon request, or at
intervals of time determined by the board, but in no case less than once every
two years, each pharmaceutical representative shall provide the following
information to the board:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   a list of practitioners
within the State contacted by the pharmaceutical representative;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   the number of times each
practitioner was contacted;</p>

<p class=MsoNormal style='line-height:150%'>     (3)   the location and
duration of each contact;</p>

<p class=MsoNormal style='line-height:150%'>     (4)   the pharmaceuticals
promoted during each contact;</p>

<p class=MsoNormal style='line-height:150%'>     (5)   whether product samples,
materials, or gifts of any value were provided to a practitioner, and the value
of the product samples, materials, or gifts provided to the practitioner; and</p>

<p class=MsoNormal style='line-height:150%'>     (6)   whether the practitioner
was compensated by the pharmaceutical representative for the contact and the
amount of compensation provided to the practitioner.</p>

<p class=MsoNormal style='line-height:150%'>     b.    The board shall
prescribe a form upon which pharmaceutical representatives provide the
information required pursuant to subsection a. of this section.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     8.    The board shall
establish proper conduct and professional standards of practice for
pharmaceutical representatives, including, but not limited to, providing that
no pharmaceutical representative shall:</p>

<p class=MsoNormal style='line-height:150%'>     a.     engage in any deceptive
or misleading marketing of a pharmaceutical, including the knowing concealment,
suppression, omission, misleading representation, or misstatement of any
material fact;</p>

<p class=MsoNormal style='line-height:150%'>     b.    use a title or
designation that could reasonably lead a practitioner, or any employee or
representative of a practitioner, to believe that the pharmaceutical
representative is licensed to practice medicine and surgery, nursing,
dentistry, optometry, pharmacy, or other similar health occupation in this
State, unless the pharmaceutical representative currently holds such license;
or</p>

<p class=MsoNormal style='line-height:150%'>     c.     attend patient
examinations without the consent of the patient.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     9.    In addition to the
provisions of section 8 of P.L.1978, c.73 (C.45:1-21), the board may suspend or
revoke the license of a pharmaceutical representative upon proof satisfactory
to the board that the pharmaceutical representative is guilty of grossly
unprofessional conduct, including a violation of any of the ethical and
professional standards established pursuant to section 8 of this act, or any
other violation of this act.  No individual whose license is revoked for any
cause shall be granted a license under this act for a period of two years from
the date of revocation.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     10.  This act shall take
effect on the 90th day next following enactment, except that the New Jersey
State Board of Medical Examiners may take any anticipatory administrative
action in advance as shall be necessary for the implementation of this act.<br
clear=all style='page-break-before:always'>
</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     This bill requires the
licensure of pharmaceutical representatives.  Under the bill, licensing of
pharmaceutical representatives will be conducted by the State Board of Medical
Examiners, which will also have several powers and duties concerning the regulation
of pharmaceutical representatives licensed under the bill.  </p>

<p class=MsoNormal style='line-height:150%'>     Pharmaceutical
representative is defined in the bill as an individual licensed by this State
to engage in the marketing or promoting of pharmaceuticals to practitioners. 
To be eligible for licensure, an applicant must be at least 18 years of age, be
of good moral character, complete a professional education course and provide
sufficient evidence that the course was completed, provide any other
information that the board may deem necessary, and pay any fees prescribed by
the board.</p>

<p class=MsoNormal style='line-height:150%'>     The bill requires each
pharmaceutical representative, as a condition of biennial license renewal, to
complete a minimum of six hours of continuing education.  The continuing
education must include training in the areas of ethics, pharmacology, laws and
regulations applicable to pharmaceutical marketing, prescription opioid drugs
and alternatives to opioids for managing and treating pain, and any other areas
the board may determine.</p>

<p class=MsoNormal style='line-height:150%'>     The bill provides that upon request,
or at intervals of time determined by the board, but in no case less than once
every two years, each pharmaceutical representative will provide the following
information to the board:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   a list of practitioners
within the State contacted by the pharmaceutical representative;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   the number of times each
practitioner was contacted;</p>

<p class=MsoNormal style='line-height:150%'>     (3)   the location and
duration of each contact;</p>

<p class=MsoNormal style='line-height:150%'>     (4)   the pharmaceuticals
promoted during each contact;</p>

<p class=MsoNormal style='line-height:150%'>     (5)   whether product samples,
materials, or gifts of any value were provided to a practitioner, and the value
of the product samples, materials, or gifts provided to the practitioner; and</p>

<p class=MsoNormal style='line-height:150%'>     (6)   whether the practitioner
was compensated by the pharmaceutical representative for the contact and the
amount of compensation provided to the practitioner.</p>

<p class=MsoNormal style='line-height:150%'>     Under the bill, the board is
required to establish proper conduct and professional standards of practice for
pharmaceutical representatives.  Among those standards adopted by the board,
the bill requires that the standards ensure that no pharmaceutical
representative will:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   engage in any deceptive
or misleading marketing of a pharmaceutical, including the knowing concealment,
suppression, omission, misleading representation, or misstatement of any
material fact;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   use a title or
designation that could reasonably lead a practitioner, or any employee or
representative of a practitioner, to believe that the pharmaceutical
representative is licensed to practice medicine and surgery, nursing,
dentistry, optometry, pharmacy, or other similar health occupation in this
State, unless the pharmaceutical representative currently holds such license;
or</p>

<p class=MsoNormal style='line-height:150%'>     (3)   attend patient
examinations without the consent of the patient.</p>

<p class=MsoNormal style='line-height:150%'>     Finally, the bill provides
that the board may suspend or revoke the license of a pharmaceutical
representative upon proof satisfactory to the board that the pharmaceutical
representative is guilty of grossly unprofessional conduct, including a
violation of any of the proper conduct and professional standards established
by the board, or any other violation of the provisions of the bill.</p>

</div>

</body>

</html>
